Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Indivumed Services’ Hamburg Site Receives College of American Pathologists (CAP) Accreditation

Indivumed Services GmbH, a Crown Bioscience company, announced that its Hamburg site received laboratory accreditation from the College of American Pathologists (CAP). The CAP accreditation, recognized as the gold standard for laboratory quality control in the industry, is reserved for top-tier laboratories that meet and maintain the highest standards of quality, accuracy, and consistency in the testing of clinical biospecimens. This distinction places Indivumed Services among the top 10% of laboratories globally, solidifying its commitment to excellence in laboratory services.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230911457952/en/

Indivumed Services CAP Accreditation Mark (Graphic: Business Wire)

Indivumed Services CAP Accreditation Mark (Graphic: Business Wire)

This achievement strengthens Indivumed Services’ global reputation in providing and analyzing clinical biospecimens, while paving the way for future Clinical Laboratory Improvement Amendments (CLIA) certification. This certification will enable the analysis of patient-derived samples across all clinical trial phases, ensuring expert end-to-end support from assay development utilizing Indivumed Services’ industry leading biobank, through to analyzing samples from downstream clinical research.

Overall, Indivumed Services’ CAP accreditation enhances its flexibility and enables the expansion of its services into new markets. This will foster stronger partnerships, ultimately benefiting both existing and new customers.

Simone Hubo, PhD, Vice President of Quality and Regulatory Affairs at Indivumed Services, stated: “With this accreditation, our customers can rest assured that the samples and analyses provided by Indivumed Services are of industry-leading quality. This means they can have confidence that the laboratory is performing at the highest global standard for quality.”

Armin Spura, PhD, Chief Executive Officer of Crown Bioscience, added: “When Crown Bioscience identified Indivumed Services as a potential acquisition, one of the key attributes that attracted us was the high quality of the operations teams and their ability to continue to support clients through the transition from preclinical to clinical development. Obtaining CAP accreditation validates this assessment and solidifies our commitment to advancing our translational research platforms so that we can provide superior options for bridging the gap between preclinical and clinical research. This achievement is a testament to the expertise of our highly qualified professionals and the cutting-edge technologies they expertly use.”

###

About Indivumed Services

Indivumed Services boasts a highly curated and characterized biobank, comprising nearly one million samples with associated clinical data. In addition, the company has established a wide-reaching network of more than 60 clinical sites spanning the United States, Europe, and Asia. This network provides direct and controlled access to surgical biospecimens, and blood samples annotated with comprehensive clinical data, all obtained in accordance with unique SOPs to standardize ischemia time, ensuring quality and suitability for multi-omics analyses and model development. Indivumed Services is a wholly owned subsidiary of Crown Bioscience and maintains operations in Germany and the United States.

For more information, please visit http://www.indivumedservices.com

About Crown Bioscience

Crown Bioscience, a JSR Life Sciences company, is a global CRO that provides preclinical and translational platforms to help our customers advance their research and development in oncology, immuno-oncology, and immune-mediated inflammatory diseases. We are the exclusive preclinical CRO to offer tumor organoid services with the well-established Hubrecht Organoid Technology. In addition, we have developed the largest commercially available PDX collection in the world. We focus on helping our customers develop novel therapies to maximize the chances that patients receive the right treatment at the right time. Founded in 2006, Crown Bioscience has 14 facilities across the United States, Europe, and Asia.

For more information, please visit www.crownbio.com

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.